Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of cancer therapy-related diarrhea
OnTarget results in breast cancer patients have been submitted to a relevant oncology conference
Read More
Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada
Read More
The Health and Fitness Summit is hosted by MEFITPRO, the leading distributor of best-in-class brands in the Gulf region
Gulf countries (the "GCC") are growing quickly and fitness adoption is outpacing GDP growth
MEFITPRO distributes CLMBR exclusively in the region and received its six-figure initial order in the third quarter
